Dr. Micheal Patrick Macken, MD

Dr. Macken practices at Northwestern Memorial Hospital - Lavin Family Pavilion Recovery Room - HOPD in Chicago, Illinois.

Dr. Macken's NPI, 1336110550, was assigned on January 27, 2006. Dr. Macken holds Illinois license 036102617.

Dr. Macken's primary practice is Northwestern Memorial Hospital - Lavin Family Pavilion Recovery Room - HOPD, at 259 E Erie St, Chicago, IL 60611.

Dr. Macken's primary practice is Northwestern Memorial Hospital - Lavin Family Pavilion Recovery Room - HOPD in Chicago, Illinois. Dr. Macken is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Macken to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account. Dr. Macken's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Macken practices, 9 sites in all. Vendor and product names are available with a free account.

Clinical neurophysiology is Dr. Macken's primary specialty in the NPI Registry, under taxonomy code 2084N0600X. Dr. Macken is licensed in Illinois.

CMS data shows 1,019 Medicare services from Dr. Macken across 13 procedure codes in 2024, for 503 Medicare patients. Medicare paid $80,313 for them.

CMS counts 503 Medicare patients who saw Dr. Macken in 2024. The largest group is 65 to 74, with 198 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Macken's median patient age at 60, with 47% women.

In 2024, Dr. Macken wrote 2,442 Medicare Part D claims for 289 patients. 79% of them were for generic drugs. CMS names the drug for 2,288 of them, across 35 drugs with 11 or more claims each, at $1,190,157 in total drug cost. In 2023, CMS named 1,838 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Macken for performance year 2024, reported through an alternative payment model (APM). Dr. Macken accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Macken as offering telehealth.

Dmand AI links 9 papers to Dr. Macken, published from 2011 to 2025. The most frequent topics are Electroencephalography, Epilepsy and Anticonvulsants. Dr. Macken has published most often in Epilepsy Behav. Dr. Macken's most frequent co-authors are Elizabeth Erway Gerard, MD, Jay R. Gavvala, MD and Aditi Pradeep Narechania, MD.

CMS Open Payments shows 1,215 general payments to Dr. Macken from 12 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. UCB, Inc. paid the most, $252,320.